Search Main Menu Main Content
  • Change contrast :
Haute Autorité de Santé
logo HAS
icone
  • HAS profile
    • Mission
    • Organisational Structure
    • Ethics, transparency and management of conflicts of interest
  • International relations and projects
  • Publications
  1. Recherche
  • icone plus

  • My account

    • Email alert Subscription
    • Newsletter Subscription
    • My search
    Refresh
    Please fill in your email address to retrieve your email alerts subscriptions.
    New subscription
    Please fill in your email address to retrieve your newsletter subscriptions.

    You do not have a saved search

  • No element in selection

  • Contact

1 result

  • Topics : Immunologic deficiency syndromes
  • Active substance : maraviroc
Filter
Topic
  • Economics and public health (1)
  • Plus ...
    • Health economics (1)
    • Screening, prevention (1)
  • Diseases and conditions (1)
  • Plus ...
    • Infectious diseases (1)
    • Plus ...
      • Sexually transmitted diseases (1)
      • Virus diseases (1)
    • Immune system diseases (1)
    • Plus ...
      • Immunologic deficiency syndromes (1)
Content type
  • Practice Guidelines and Other Guides (1)
  • Plus ...
    • Public Health guideline (1)
Manufacturer
  • inconnu (1)
Language
  • Français (1)
Active substance
  • alcool (1)
  • dapsone (1)
  • emtricitabine (1)
  • enfuvirtide (1)
  • lamivudine (1)
  • maraviroc (1)
  • ritonavir (1)
  • saquinavir (1)
  • zidovudine (1)

Practice guidelines and other guides - 1 result

  • HIV infection screening in France - Screening Strategies

    Public Health guideline - Posted on 21/10/2009
    Download abstract
    Add to my selection
Haute Autorité de Santé
Advancing quality in the fields of health and social care services

Follow us :

  • Twitter (nouvelle fenêtre)
  • Facebook (nouvelle fenêtre)
  • Youtube (nouvelle fenêtre)
  • LinkedIn (nouvelle fenêtre)
  • Eunetha.eu
  • Pasq.eu
  • All our publications by topic and type
  • Opinions on medicines
  • Opinions on medical devices
  • INAHTA briefs
  • fr Français
  • en English
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
KHAn1M1BPm7fRQJv